Journal Report

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA

Download PDF
Journal Information
Journal Title
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA
Publisher
CIG MEDIA GROUP, LP
ISSN
2152-2650
E-ISSN
2152-2669
Database
Clarivate
Domain
Health Sciences, Life Sciences, Social Sciences
Classification History
Year A+ A B C
2026 ✓ ✓
2025 ✓ ✓
2024 ✓ ✓
2023 ✓
2021/2022 ✓
2020 ✓
2019 ✓
2018 ✓
A journal may have more than one classification in the same year. All recorded classifications are displayed.
Recent Articles
Acute Leukemia During the First Six Months of Life: A Population-Based Analysis of Survival by Leukemia Type
Cristina A. Perez-Witte, Natalie Wu, Philip T. Pauerstein et al.
2026-11 Vol. 26 Issue 11 Pages e1294-e1299
DOI: 10.1016/j.clml.2026.08.013
SOHO State of the Art Updates and Next Questions | The Role of Maintenance Therapy Following Autologous Stem Cell Transplantation for Newly Diagnosed Multiple Myeloma
Bradley Uyemura, Natalie S. Callander
2026-11 Vol. 26 Issue 11 Pages 711-720
DOI: 10.1016/j.clml.2026.07.014
Corrigendum to “Epcoritamab Monotherapy as Outpatient Treatment for Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Interim Results From EPCORE NHL-6”[Clinical Lymphoma Myeloma and Leukemia 26 (2026) 317–327]
David Andorsky, Adelba Torres Lopez, Rakhee Vaidya et al.
2026-11 Vol. 26 Issue 11 Pages e1275-e1277
DOI: 10.1016/j.clml.2026.08.006
SOHO State of the Art Updates and Next Questions | Chronic Myeloid Leukemia in Low- and Middle-Income Countries: Increasing Access to Tyrosine Kinase Inhibitors and Supporting Treatment Free Remission
Pat Garcia-Gonzalez, Colin Forsyth, Lauren Herzog et al.
2026-11 Vol. 26 Issue 11 Pages 721-728
DOI: 10.1016/j.clml.2026.08.003
Increased Overall Survival for Subcutaneous Versus Intravenous Daratumumab in Medicare Beneficiaries With Multiple Myeloma
Daniel Gomes, Phillip Sarocco, Charles P. Theuer et al.
2026-11
DOI: 10.1016/j.clml.2026.08.016
Supportive Care in Multiple Myeloma: Evidence-Based Recommendations From the Intergroupe Francophone du Myélome (IFM)
Laurent Frenzel, Pascal Godmer, Alexis Talbot et al.
2026-11 Vol. 26 Issue 11 Pages e1366-e1379
DOI: 10.1016/j.clml.2026.09.008
Patient-reported Outcomes and Healthcare Provider Perspectives on Subcutaneous Isatuximab Delivery via On-body Injector Versus Manual Injection: Results From the Phase 2 IZALCO Study in Relapsed/Refractory Multiple Myeloma
Gurdeep Parmar, Marcelo Capra, Vania Hungria et al.
2026-11 Vol. 26 Issue 11 Pages 768-780.e5
DOI: 10.1016/j.clml.2026.08.019
Table of Contents
2026-11 Vol. 26 Issue 11 Pages A3-A6
DOI: 10.1016/s2152-2650(26)04020-6
Editorial Board
2026-11 Vol. 26 Issue 11 Pages A1-A2
DOI: 10.1016/s2152-2650(26)04019-x
Real-World Experience With Mogamulizumab for Mycosis Fungoides and Sézary Syndrome
Charalampos Filippatos, Maria Gavriatopoulou, Alexandros Briasoulis et al.
2026-11 Vol. 26 Issue 11 Pages e1278-e1286.e1
DOI: 10.1016/j.clml.2026.08.018
Articles retrieved from Crossref.
Green Journals | https://www.green-journals.com | info@green-journals.com
Printed: November 5, 2026 16:03